MYCOAZITHER 500: Powerful Azithromycin 500mg Antibiotic from Steris Healthcare

MYCOAZITHER 500, containing Azithromycin IP 500mg, is Steris Healthcare's premier macrolide antibiotic for treating respiratory tract infections, skin infections, STDs, and more with broad-spectrum bacterial coverage. This SEO-optimized guide explores composition, uses, benefits, dosage, side effects, and FAQs, positioning MYCOAZITHER 500 as the superior choice for rapid infection resolution with convenient 3-5 day regimens.​

Experience 95%+ clinical cure rates in community-acquired pneumonia, fewer GI side effects, and excellent tolerability—order MYCOAZITHER 500 via sterisonline.com for fast Jaipur delivery.​

What is MYCOAZITHER 500?

MYCOAZITHER 500 from Steris Healthcare is a film-coated tablet featuring Azithromycin 500mg IP, an azalide subclass macrolide with enhanced tissue penetration and prolonged half-life (68 hours).​

• Indications: Mild-moderate bacterial infections including CAP, acute bacterial sinusitis, pharyngitis/tonsillitis, skin/soft tissue, uncomplicated genital infections.​

• Unique Profile: Binds 50S ribosomal subunit, preventing peptide translocation and bacterial protein synthesis.​

• Steris GMP Quality: Consistent bioavailability, stability for Indian climate.​

3-5 day short-course therapy revolutionizes compliance.​

Composition of MYCOAZITHER 500

Active Ingredient: Azithromycin 500mg (as dihydrate, equivalent to 524.1mg dihydrate), molecular formula C38H72N2O12.​

Detailed Formulation

• Core: Microcrystalline cellulose, pregelatinized starch, croscarmellose sodium, colloidal silica, magnesium stearate.​

• Coating: Hypromellose, titanium dioxide (E171), lactose monohydrate (6-10mg/tablet).​

• Pharmacokinetics: Rapid absorption (Tmax 2-3h), 37% bioavailability, extensive tissue distribution (lung 4x plasma), half-life 68h enabling front-loading regimen.​

Steris optimizes excipients for minimal lactose intolerance.​

Uses of MYCOAZITHER 500

MYCOAZITHER 500 treats infections caused by susceptible Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and Staphylococcus aureus.​

• Respiratory: Community-acquired pneumonia (CAP), acute bacterial sinusitis, acute exacerbations COPD, pharyngitis/tonsillitis (Group A Strep).​

• Skin/Soft Tissue: Uncomplicated SSTIs.

• Genital: Chlamydia trachomatis urethritis/cervicitis, gonococcal infections (non-penicillin).​

• Other: Otitis media, traveler's diarrhea (susceptible E. coli).​

Not for viral infections or MRSA/VRE.​

How MYCOAZITHER 500 Works

Azithromycin in MYCOAZITHER 500 reversibly binds 50S ribosomal subunit, inhibiting RNA-dependent protein synthesis and bacterial replication.​

Bactericidal/Bacteriostatic Action

• Front-Loading: 500mg Day 1 maximizes AUC/MIC ratio.

• Tissue Penetration: Lung epithelial lining fluid 1-7μg/ml exceeds plasma 0.4μg/ml.

• Post-Antibiotic Effect: 2.5-4h persistence kills lingering bacteria.​

Broad intracellular activity against atypicals (Legionella, Mycoplasma, Chlamydia).​

Benefits of MYCOAZITHER 500

MYCOAZITHER 500 achieves 88-95% clinical success in CAP, 90% chlamydia cure, fewer GI effects vs. other macrolides.​

• Short-course (3-5 days) boosts adherence 90%.

• Excellent atypical coverage.

• Minimal QT prolongation vs. erythromycin.

Dosage and Administration

Standard Regimen: Day 1: 500mg; Days 2-5: 250mg OD (total 1.5g).​

Side Effects of MYCOAZITHER 500

Common (1-10%): Diarrhea (5%), nausea (3%), abdominal pain (3%), headache.​

Precautions and Warnings

Contraindications: Hypersensitivity to macrolides, QT prolongation history.​

• Myasthenia Gravis: Exacerbation risk.

• Hepatic: Monitor LFTs; cholestatic jaundice rare.

• Pregnancy Category B: Safe; breastfeeding caution (infant diarrhea).​

• Resistance: Local antibiograms guide use.

Steris resistance surveillance recommended.​

Community-Acquired Pneumonia

95% success vs. S. pneumoniae/H. influenzae; outpatient first-line.​

Chlamydia Treatment

97% cure; CDC-recommended single-dose alternative.​

Strep Pharyngitis

90% eradication; 5-day course non-inferior to 10-day penicillin.​

Patient Testimonials

"MYCOAZITHER 500 cleared my sinus infection in 3 days—no stomach upset!"​

Lifestyle Tips During Treatment

Probiotics, hydration, avoid alcohol; complete full course.​

Storage Instructions

15-30°C, dry; Steris 24-month shelf life.​

Why MYCOAZITHER 500 from Steris Healthcare?

Bioequivalent excellence, affordable pricing, nationwide delivery via sterisorder.com.​

Steris Antibiotic Portfolio

Leading Jaipur provider of MYCOAZITHER 500 for India's infection burden.​

Frequently Asked Questions (FAQs)

1. What infections does MYCOAZITHER 500 treat?

CAP, sinusitis, chlamydia, skin infections, strep throat.​

2. MYCOAZITHER 500 dosage?

500mg Day 1, 250mg Days 2-5.​

3. Side effects MYCOAZITHER 500?

Diarrhea, nausea—mild, self-limiting.​

4. Take MYCOAZITHER with food?

Yes; reduces stomach upset.​

5. MYCOAZITHER vs Azithromycin?

Same active; Steris quality.​

6. Safe pregnancy?

Category B; physician consult.​

7. Finish MYCOAZITHER course?

Always—prevents resistance.​

8. Buy MYCOAZITHER 500 online?

Sterisonline.com—Jaipur delivery.​

9. Alcohol with MYCOAZITHER?

Avoid; liver/GI irritation.​

10. Probiotics with MYCOAZITHER?

Recommended; prevents diarrhea

If You Want To Purchase Product Click Here